|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | C07K 16/08 | (2006.01) |
| A61K 39/21 | (2006.01) | ||
| C07K 16/10 | (2006.01) |
| (11) | Number of the document | 2710033 |
| (13) | Kind of document | T |
| (96) | European patent application number | 12785929.6 |
| Date of filing the European patent application | 2012-05-17 | |
| (97) | Date of publication of the European application | 2014-03-26 |
| (45) | Date of publication and mention of the grant of the patent | 2021-01-20 |
| (46) | Date of publication of the claims translation | 2021-06-10 |
| (86) | Number | PCT/US2012/038400 |
| Date | 2012-05-17 |
| (87) | Number | WO 2012/158948 |
| Date | 2012-11-22 |
| (30) | Number | Date | Country code |
| 201161486960 P | 2011-05-17 | US |
| (72) |
SCHEID, Johannes, US
NUSSENZWEIG, Michel, US
BJORKMAN, Pamela, J., US
DISKIN, Ron, US
|
| (73) |
The Rockefeller University,
1230 York Avenue, New York, NY 10065,
US
California Institute of Technology, 1200 East California Boulevard M/C 6-32, Pasadena, CA 91125, US |
| (74) |
Jurga PETNIŪNAITĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
| (54) | Žmogaus imunodeficito virusą neutralizuojantys antikūnai ir jų panaudojimo būdai |
| HUMAN IMMUNODEFICIENCY VIRUS NEUTRALIZING ANTIBODIES AND METHODS OF USE THEREOF |
| Payment date | Validity (years) | Amount | |
| 2025-05-05 | 14 | 289.00 EUR |
| 2026-05-17 |